Standex International Corporation (SXI) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary and Q&A reveal strong financial performance, including record adjusted gross margin and successful product development. The acquisition of McStarlite expands the market, and plans for global expansion are underway. Despite some uncertainties in the EV market and NIH funding, optimistic guidance and strategic plans are in place. The company's debt leverage is expected to improve, and the acquisition pipeline remains active. Overall, the positive aspects outweigh the concerns, suggesting a likely positive stock price movement.
Key Financial Performance
Sales Growth Sales increased 23.2% year-over-year, driven by acquisitions and a slight organic decline. Electronics grew slightly on an organic basis with organic orders up 16% year-on-year. The growth was attributed to acquisitions and strong demand in fast growth markets.
Adjusted Operating Margin Achieved a record adjusted operating margin of 20.6%, up 350 basis points year-over-year. This was driven by contributions from acquisitions, pricing and productivity initiatives, and favorable product mix.
Adjusted Earnings Per Share (EPS) Adjusted EPS increased 20.6% year-over-year to a record $2.28. This was due to higher operating income and revenue growth.
Net Cash Provided by Operating Activities Net cash provided by operating activities was $33.4 million, up from $28.7 million a year ago. The increase was due to higher profitability.
Free Cash Flow Free cash flow increased to $24.9 million from $22.2 million a year ago, driven by higher operating cash flow despite increased capital expenditures.
Electronics Segment Revenue Revenue increased 43.2% year-over-year to $115.2 million, driven by a 41% benefit from acquisitions, 0.3% organic growth, and 1.9% benefit from foreign currency. Growth was supported by demand in defense, power magnetic applications, and the electrical grid market.
Engineering Technologies Revenue Revenue increased 26.8% year-over-year to $32 million, driven by a 25% benefit from acquisitions, 0.9% organic growth, and 0.9% benefit from foreign currency. Growth was attributed to new product sales.
Scientific Segment Revenue Revenue increased 2.3% year-over-year to $17.9 million, driven by a 16.1% benefit from acquisitions, partially offset by a 13.9% organic decline due to lower demand from academic and research institutions impacted by NIH funding cuts.
Engraving Segment Revenue Revenue increased 0.6% year-over-year to $33 million, driven by a 1.2% benefit from foreign currency, partially offset by a 0.6% organic decline. Growth was supported by productivity initiatives and restructuring actions.
Specialty Solutions Segment Revenue Revenue decreased 1.2% year-over-year to $23.9 million, primarily due to general market softness.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New product sales: New product sales added approximately 2.8% to sales in Q4 2025, ahead of the 2% goal. Sales of new products increased from $38 million to $55 million in FY 2025. 16 new products were launched in FY 2025, and more than 15 are planned for FY 2026, expected to contribute 300 basis points of incremental growth.
Market expansion: Sales into fast growth markets increased to 28% of total company sales in Q4 2025. FY 2025 sales into fast growth markets were $184 million, exceeding the $170 million expectation. FY 2026 sales into these markets are expected to grow by 45% to exceed $265 million. A new site in Croatia was established to serve European customers, with shipments expected within 4 months.
Operational efficiencies: Record adjusted operating margin of 20.6% in Q4 2025, up 120 basis points sequentially and 350 basis points year-on-year. Adjusted gross margin and adjusted operating margin expanded by over 200 basis points in FY 2025. Net leverage ratio reduced to 2.6x through profit generation and debt paydown.
Acquisitions and integration: Two acquisitions in FY 2025 increased presence in electrical grid, space, and defense markets. Expansion plans for Amran/Narayan in Houston and India are underway, and a greenfield site in Croatia is being commissioned to support European customers.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Organic Revenue Decline: The company experienced a 1.4% organic revenue decline in Q4 2025, which could indicate challenges in maintaining organic growth.
Seasonality in Europe: Seasonality in Europe is expected to impact revenue and adjusted operating margin in the Electronics and Engraving segments in fiscal Q1 2026.
NIH Funding Cuts: Lower demand from academic and research institutions due to NIH funding cuts has negatively impacted the Scientific segment, leading to a 13.9% organic decline.
Product Mix Challenges: Adjusted operating margins in the Engineering Technologies and Scientific segments were negatively impacted by unfavorable product mix.
General Market Softness: The Specialty Solutions segment experienced a 1.2% revenue decline due to general market softness, which could persist.
Debt Leverage: The company has a net debt of $448 million and a net leverage ratio of 2.6x, which could pose financial risks if economic conditions worsen.
Economic and Trade Disruptions: The company’s fiscal 2026 outlook assumes no unforeseen economic, global trade, or tariff-related disruptions, which remain potential risks.
Integration of Acquisitions: The success of recent acquisitions is critical to growth, but challenges in integration or underperformance could impact financial results.
Dependence on Fast Growth Markets: The company’s reliance on fast growth markets for significant revenue growth could be risky if these markets underperform or face disruptions.
Customer Adoption Delays: New product sales depend on customer adoption, which involves internal approvals and engineering validation, potentially delaying revenue realization.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: In fiscal year 2026, the company expects revenue to grow by over $100 million, driven by mid- to high single-digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and contributions from recent acquisitions.
New Product Sales: New product sales are expected to contribute approximately 300 basis points of incremental sales growth in fiscal year 2026, with more than 15 new products planned for release.
Sales in Fast Growth Markets: Sales in fast growth markets are projected to grow approximately 45% year-on-year, exceeding $265 million in fiscal year 2026.
Operating Margin: The company anticipates continued adjusted operating margin expansion in fiscal year 2026.
Segment-Specific Outlook: Electronics: Sequentially, slightly lower revenue is expected in fiscal Q1 2026 due to seasonality in Europe, but significant year-on-year revenue growth and adjusted operating margin expansion are anticipated. Engineering Technologies: Slightly lower revenue and adjusted operating margin are expected sequentially in fiscal Q1 2026 due to project timing. Scientific: Slightly higher revenue and similar adjusted operating margin are expected sequentially in fiscal Q1 2026. Engraving: Similar revenue and slightly higher adjusted operating margin are expected sequentially in fiscal Q1 2026. Specialty Solutions: Similar revenue and slightly higher operating margin are expected sequentially in fiscal Q1 2026.
Capital Expenditures: Capital expenditures for fiscal year 2026 are expected to be between $33 million and $38 million.
Debt Leverage: The company plans to continue paying down debt and anticipates a further decline in its leverage ratio through fiscal year 2026.
Long-Term Targets: By fiscal year 2028, the company aims to achieve sales greater than $1.15 billion, an adjusted operating margin greater than 23%, and a return on invested capital (ROIC) of 12.5%.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Cash Dividend: Declared 244th consecutive quarterly cash dividend of $0.32 per share, representing an approximately 6.7% increase year-on-year.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide insights into the $100 million or more revenue increase projected for fiscal '26?
A:The $100 million revenue increase is based on the full-year impact of acquisitions ($60 million+), new products ($20 million+), and growth in fast-growth markets like defense, space commercialization, and grid technologies ($38 million). The estimate is conservative, and the total could range from $100 million to $130 million or more.
Q:How is the EV business performing, given recent challenges in the market?
A:The EV business is still considered part of the fast-growth markets. While EV sales dipped slightly in fiscal '25 compared to '24, growth is expected in fiscal '26 due to new model introductions, particularly with European high-end brands.
Q:What is the expected ramp-up for the Amran business in Croatia?
A:The Croatia facility is expected to ship single-digit millions in fiscal '26, with growth to $30 million+ over three years. There is significant opportunity in Europe, and further expansion may be needed depending on customer demand.
Q:What is driving the core organic order growth in the Electronics segment?
A:Year-on-year orders in the core business are up 16% ($12 million), driven by OEMs ($10 million) and distribution ($2 million). Growth is attributed to disciplined commercial processes and a growing application funnel.
Q:What are the capacity expansion plans for Amran in North America and Europe?
A:The Croatia site could reach $30 million in three years and $60 million+ in subsequent years. In North America, expansions include second shifts in India and Texas, lean practices, and potential new sites in Houston and Mexico, depending on trade and tariff developments.
Q:Is the restructuring in the Engraving business complete?
A:Most of the heavy lifting in restructuring is done, but there may be ongoing adjustments to align with toolmaker locations. Demand in the auto OEM sector is stabilizing, and new opportunities in differentiated parts are being explored.
Q:What is the impact of NIH funding on the Scientific segment?
A:About one-third of Scientific sales are affected by NIH funding, which has impacted order rates. The fiscal '26 outlook does not assume significant changes in NIH funding, but any recovery would provide upside.
Q:What is the impact of interest rate changes on the business?
A:Interest rate changes affect debt repayment. The company aims to reduce net leverage to 2x by the end of the fiscal year, assuming the current portfolio of businesses.
Q:Is McStarlite accretive to operating margins in the ETG segment?
A:McStarlite has similar margins to the core ETG business. Revenue synergies are expected, with opportunities for designing new parts and improving efficiency.
Q:What is the impact of recent tariff announcements on the business?
A:About 4% of COGS comes from India, mostly in the Electronics segment. The company is addressing this through pricing, productivity, and alternative sourcing. Copper exposure is also being managed.
Q:What is the long-term sales target for fiscal '28, and how will it be achieved?
A:The target is $1.15 billion, driven by new products ($130 million), fast-growth markets ($380 million), and core business growth (3% annually). Additional opportunities in scientific markets, defense, and engraving could add $30-$40 million.
Q:What is the contribution of new products to fast-growth markets?
A:About 30% of new products contribute to fast-growth markets. Engineering Technologies has been a significant contributor, particularly in space commercialization.
Q:What are the incremental margin benefits of scaling fast-growth markets?
A:Fast-growth markets have margins 300-400 basis points higher than the average, contributing to the company's goal of over 23% adjusted operating margin by fiscal '28.
Q:What drove the growth in new product sales?
A:Engineering Technologies' sales in space commercialization were the biggest contributors. The company released 16 new products in the quarter, with $55 million in sales from products released in the last couple of years.
Q:Is there an appetite for acquisitions in fiscal '26?
A:Yes, the company is actively working on its acquisition pipeline and expects to have the financial capacity to pursue opportunities as net leverage decreases to 2x by the end of the fiscal year.
Q:What are the expectations for Scientific margins in fiscal '26?
A:Scientific margins are expected to hold steady despite tariff pressures, supported by pricing, productivity actions, and alternative sourcing.
Q:How will working capital improvements impact free cash flow?
A:The company aims to improve receivables and collections processes, targeting a reduction in DSO from 69-70 to the low 60s, which will enhance free cash flow conversion.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numbers for the potential Mexico site expansion and the exact impact of recent tariff announcements. Additionally, while they discussed the impact of interest rate changes and working capital improvements, the responses lacked detailed numerical clarity.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Amran Narayan
FY
Group acquisition
Inc
LLC Research
Narayan Group
Research Division
Sarcevic
acquisition benefit
acquisition sale
action
award
benefit currency
bill
book
capacity
contribution Amran
currency decline
debt leverage
decline margin
driver
effect
expansion basis
generation
inflection point
leverage ratio
margin expansion
momentum
part
product mix
product release
program
realization
seasonality Europe
shift
site
source market
success
SXI Transcript
Standex International Corporation (SXI) Q3 2026 Earnings Call Transcript
Unknown5-1
The earnings call summary indicates moderate financial performance with a 5% revenue increase and improved margins, suggesting some positive sentiment. However, the absence of new strategic initiatives or operational updates, combined with highlighted risks and uncertainties, tempers enthusiasm. The Q&A section did not provide additional clarity or insights. Given the market cap of approximately $1.9 billion, the stock price is likely to remain stable over the next two weeks, resulting in a neutral sentiment rating.
Standex International Corporation (SXI) Q2 2026 Earnings Call Transcript
Positive1-30
The earnings call and strategic plan indicate strong growth prospects, especially with raised revenue guidance and new product launches. Fast-growth market sales and new partnerships enhance this outlook. Despite some margin pressures and unclear timelines for certain investments, the overall sentiment is positive, driven by strong demand in key segments and a strategic focus on expansion. The company's market cap suggests a moderate reaction, leading to a predicted positive stock movement of 2% to 8% over the next two weeks.
Standex International Corporation (SXI) Q1 2026 Earnings Call Transcript
Positive10-31
The earnings call summary indicates strong revenue growth, especially in fast-growth markets, and a focus on new product development. The Q&A session reinforces positive momentum, with no slowdown in key growth areas and strong bookings. Despite some margin declines, the company's strategic focus on optimization and expansion into fast-growth markets is promising. The market cap suggests a moderate reaction, leading to a positive stock price movement of 2% to 8% over the next two weeks.
Standex International Corporation (SXI) Q4 2025 Earnings Call Transcript
Positive8-1
The earnings call summary and Q&A reveal strong financial performance, including record adjusted gross margin and successful product development. The acquisition of McStarlite expands the market, and plans for global expansion are underway. Despite some uncertainties in the EV market and NIH funding, optimistic guidance and strategic plans are in place. The company's debt leverage is expected to improve, and the acquisition pipeline remains active. Overall, the positive aspects outweigh the concerns, suggesting a likely positive stock price movement.
SXI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
